| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | SF3A1 |
| Uniprot No | Q15459 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-793 aa |
| 活性数据 | MPAGPVQAVP PPPPVPTEPK QPTEEEASSK EDSAPSKPVV GIIYPPPEVR NIVDKTASFV ARNGPEFEAR IRQNEINNPK FNFLNPNDPY HAYYRHKVSE FKEGKAQEPS AAIPKVMQQQ QQTTQQQLPQ KVQAQVIQET IVPKEPPPEF EFIADPPSIS AFDLDVVKLT AQFVARNGRQ FLTQLMQKEQ RNYQFDFLRP QHSLFNYFTK LVEQYTKILI PPKGLFSKLK KEAENPREVL DQVCYRVEWA KFQERERKKE EEEKEKERVA YAQIDWHDFV VVETVDFQPN EQGNFPPPTT PEELGARILI QERYEKFGES EEVEMEVESD EEDDKQEKAE EPPSQLDQDT QVQDMDEGSD DEEEGQKVPP PPETPMPPPL PPTPDQVIVR KDYDPKASKP LPPAPAPDEY LVSPITGEKI PASKMQEHMR IGLLDPRWLE QRDRSIREKQ SDDEVYAPGL DIESSLKQLA ERRTDIFGVE ETAIGKKIGE EEIQKPEEKV TWDGHSGSMA RTQQAAQANI TLQEQIEAIH KAKGLVPEDD TKEKIGPSKP NEIPQQPPPP SSATNIPSSA PPITSVPRPP TMPPPVRTTV VSAVPVMPRP PMASVVRLPP GSVIAPMPPI IHAPRINVVP MPPSAPPIMA PRPPPMIVPT AFVPAPPVAP VPAPAPMPPV HPPPPMEDEP TSKKLKTEDS LMPEEEFLRR NKGPVSIKVQ VPNMQDKTEW KLNGQVLVFT LPLTDQVSVI KVKIHEATGM PAGKQKLQYE GIFIKDSNSL AYYNMANGAV IHLALKERGG RKK |
| 分子量 | 88.8 kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是3篇关于重组人SF3A1蛋白的参考文献及其概要：
1. **"Structural insights into the role of SF3A1 in spliceosome assembly"**
*作者：Chen Y, et al. (2020)*
**摘要**：通过冷冻电镜解析SF3A1蛋白在剪接体组装中的结构作用，揭示了其与U2 snRNP复合物的互作界面，为RNA剪接调控机制提供依据。
2. **"Functional characterization of recombinant SF3A1 mutations in hematologic malignancies"**
*作者：Wang L, et al. (2018)*
**摘要**：重组SF3A1蛋白体外实验表明，其特定突变(如R625C)干扰剪接体功能，可能导致白血病中异常剪接及基因表达失调。
3. **"Expression and purification of human SF3A1 for biochemical studies"**
*作者：Kastner B, et al. (2015)*
**摘要**：开发了重组SF3A1蛋白在大肠杆菌中的高效表达与纯化方案，为剪接体复合物的体外重构及功能研究奠定技术基础。
**备注**：SF3A1相关研究多集中于其在RNA剪接中的功能及疾病突变分析，重组蛋白研究相对较少，建议结合剪接体复合物整体文献拓展阅读。
Spliceosome-associated protein SF3A1 is a critical component of the U2 small nuclear ribibonucleoprotein (snRNP) complex within the spliceosome, a dynamic molecular machinery responsible for pre-mRNA splicing in eukaryotic cells. As part of the SF3A subcomplex (composed of SF3A1. SF3A2. and SF3A3), it plays a vital role in recognizing branch site sequences and stabilizing interactions between the U2 snRNP and pre-mRNA during spliceosome assembly. The human SF3A1 gene encodes a 793-amino-acid protein containing two conserved HEAT repeat domains that mediate protein-protein interactions.
Recombinant human SF33A1 protein is typically expressed in vitro using systems like E. coli or mammalian cells, enabling functional studies of spliceosome dynamics. Its recombinant form facilitates investigations into alternative splicing mechanisms, structural analyses (e.g., cryo-EM studies), and high-throughput screening of spliceosome-modulating compounds. Aberrant SF3A1 expression or mutations have been linked to hematologic malignancies and solid tumors, making it a potential therapeutic target. Recent studies focus on developing SF3A1-targeting small molecules (e.g., pladienolide derivatives) that disrupt spliceosome integrity in cancer cells. Researchers also utilize recombinant SF3A1 to model splicing errors associated with genetic disorders and to engineer splice-switching antisense oligonucleotides. Its conserved function across species further supports cross-organismal studies of fundamental splicing mechanisms.
×
